China's Finance Ministry Injects RMB 35 Billion into China Life Group
China's Ministry of Finance will inject RMB 35 billion into China Life Insurance (Group) Company to strengthen its operational stability and risk resilience. The capital injection, announced on September 6, aims to support the insurer's core business, improve governance, and promote differentiated development, aligning with national efforts to enhance financial services for the real economy and high-quality growth of the insurance sector.
On September 6, China Life Insurance (Group) Company announced that the Ministry of Finance will inject RMB 35 billion into the group. The capital injection is intended to further enhance China Life's operational stability and risk resilience, providing momentum for the company to focus on its core business, improve governance, and pursue differentiated development.
The group stated that the injection is a significant measure by the state to strengthen the capacity of financial services for the real economy and promote high-quality development of the financial and insurance sectors, fully reflecting the state's high regard and strong support for advancing high-quality growth in the industry. China Life will treat this capital replenishment as a new starting point for high-quality development, further leveraging its role as an economic shock absorber and social stabilizer through insurance, fulfilling the "five major articles" in finance, and striving to serve as a main force in supporting the real economy and a cornerstone for maintaining financial stability, contributing to Chinese-style modernization.